Market Closed -
Nyse
01:30:02 01/05/2024 am IST
|
5-day change
|
1st Jan Change
|
67.71
USD
|
+0.39%
|
|
-1.15%
|
-14.25%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
96,649
|
89,399
|
1,36,274
|
1,22,449
|
1,01,613
|
85,347
|
-
|
-
|
Enterprise Value (EV)
1 |
1,59,446
|
1,46,192
|
1,79,925
|
1,60,658
|
1,51,768
|
1,33,444
|
1,28,773
|
1,21,161
|
P/E ratio
|
14.6
x
|
12.5
x
|
17.3
x
|
29.7
x
|
12.2
x
|
9.88
x
|
8.77
x
|
7.78
x
|
Yield
|
2.69%
|
2.93%
|
1.94%
|
2.36%
|
3.06%
|
3.9%
|
4.16%
|
4.51%
|
Capitalization / Revenue
|
0.38
x
|
0.33
x
|
0.47
x
|
0.38
x
|
0.28
x
|
0.23
x
|
0.22
x
|
0.2
x
|
EV / Revenue
|
0.62
x
|
0.54
x
|
0.62
x
|
0.5
x
|
0.42
x
|
0.36
x
|
0.33
x
|
0.29
x
|
EV / EBITDA
|
9.23
x
|
8.07
x
|
9.2
x
|
8.04
x
|
7.59
x
|
6.83
x
|
6.17
x
|
5.56
x
|
EV / FCF
|
15.3
x
|
10.9
x
|
11.4
x
|
11.9
x
|
14.6
x
|
14.5
x
|
11.4
x
|
9.87
x
|
FCF Yield
|
6.52%
|
9.19%
|
8.75%
|
8.37%
|
6.85%
|
6.89%
|
8.77%
|
10.1%
|
Price to Book
|
1.51
x
|
1.29
x
|
1.81
x
|
1.71
x
|
1.33
x
|
1.03
x
|
0.93
x
|
0.82
x
|
Nbr of stocks (in thousands)
|
13,00,964
|
13,08,913
|
13,21,000
|
13,13,967
|
12,86,897
|
12,60,480
|
-
|
-
|
Reference price
2 |
74.29
|
68.30
|
103.2
|
93.19
|
78.96
|
67.71
|
67.71
|
67.71
|
Announcement Date
|
12/02/20
|
16/02/21
|
09/02/22
|
08/02/23
|
07/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,56,776
|
2,68,706
|
2,92,111
|
3,22,467
|
3,57,776
|
3,70,882
|
3,92,956
|
4,18,003
|
EBITDA
1 |
17,274
|
18,108
|
19,565
|
19,971
|
19,995
|
19,539
|
20,884
|
21,789
|
EBIT
1 |
15,339
|
16,008
|
17,312
|
17,532
|
17,534
|
16,729
|
17,630
|
18,668
|
Operating Margin
|
5.97%
|
5.96%
|
5.93%
|
5.44%
|
4.9%
|
4.51%
|
4.49%
|
4.47%
|
Earnings before Tax (EBT)
1 |
8,997
|
9,770
|
10,420
|
5,628
|
11,173
|
11,928
|
13,211
|
14,482
|
Net income
1 |
6,634
|
7,179
|
7,910
|
4,149
|
8,344
|
8,882
|
9,764
|
10,631
|
Net margin
|
2.58%
|
2.67%
|
2.71%
|
1.29%
|
2.33%
|
2.39%
|
2.48%
|
2.54%
|
EPS
2 |
5.080
|
5.460
|
5.950
|
3.140
|
6.470
|
6.851
|
7.718
|
8.701
|
Free Cash Flow
1 |
10,391
|
13,428
|
15,745
|
13,450
|
10,395
|
9,197
|
11,300
|
12,279
|
FCF margin
|
4.05%
|
5%
|
5.39%
|
4.17%
|
2.91%
|
2.48%
|
2.88%
|
2.94%
|
FCF Conversion (EBITDA)
|
60.15%
|
74.16%
|
80.48%
|
67.35%
|
51.99%
|
47.07%
|
54.11%
|
56.35%
|
FCF Conversion (Net income)
|
156.63%
|
187.05%
|
199.05%
|
324.17%
|
124.58%
|
103.55%
|
115.73%
|
115.5%
|
Dividend per Share
2 |
2.000
|
2.000
|
2.000
|
2.200
|
2.420
|
2.642
|
2.815
|
3.056
|
Announcement Date
|
12/02/20
|
16/02/21
|
09/02/22
|
08/02/23
|
07/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
73,794
|
76,604
|
76,826
|
80,636
|
81,159
|
83,846
|
85,278
|
88,921
|
89,764
|
93,813
|
89,204
|
92,104
|
92,735
|
96,768
|
94,693
|
EBITDA
1 |
4,646
|
4,733
|
5,070
|
5,431
|
4,825
|
4,645
|
4,969
|
5,100
|
5,074
|
4,852
|
4,186
|
5,123
|
5,172
|
4,939
|
4,885
|
EBIT
1 |
4,073
|
4,147
|
4,483
|
4,810
|
4,233
|
4,006
|
4,370
|
4,481
|
4,456
|
4,227
|
3,560
|
4,439
|
4,496
|
4,304
|
4,107
|
Operating Margin
|
5.52%
|
5.41%
|
5.84%
|
5.97%
|
5.22%
|
4.78%
|
5.12%
|
5.04%
|
4.96%
|
4.51%
|
3.99%
|
4.82%
|
4.85%
|
4.45%
|
4.34%
|
Earnings before Tax (EBT)
1 |
2,145
|
1,570
|
2,946
|
4,029
|
-4,456
|
3,109
|
2,879
|
2,570
|
3,019
|
2,705
|
2,428
|
2,912
|
2,979
|
2,837
|
3,208
|
Net income
1 |
1,598
|
1,306
|
2,312
|
2,951
|
-3,416
|
2,302
|
2,136
|
1,901
|
2,261
|
2,046
|
1,713
|
2,355
|
2,411
|
2,292
|
2,140
|
Net margin
|
2.17%
|
1.7%
|
3.01%
|
3.66%
|
-4.21%
|
2.75%
|
2.5%
|
2.14%
|
2.52%
|
2.18%
|
1.92%
|
2.56%
|
2.6%
|
2.37%
|
2.26%
|
EPS
2 |
1.200
|
0.9800
|
1.740
|
2.230
|
-2.600
|
1.750
|
1.650
|
1.480
|
1.750
|
1.580
|
1.316
|
1.804
|
1.872
|
1.800
|
1.719
|
Dividend per Share
2 |
0.5000
|
0.5000
|
0.5500
|
0.5500
|
0.5500
|
0.5500
|
0.6050
|
0.6050
|
0.6050
|
0.6050
|
0.6614
|
0.6614
|
0.6614
|
0.6614
|
0.7195
|
Announcement Date
|
03/11/21
|
09/02/22
|
04/05/22
|
03/08/22
|
02/11/22
|
08/02/23
|
03/05/23
|
02/08/23
|
01/11/23
|
07/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
62,797
|
56,793
|
43,651
|
38,209
|
50,155
|
48,097
|
43,426
|
35,814
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.635
x
|
3.136
x
|
2.231
x
|
1.913
x
|
2.508
x
|
2.462
x
|
2.079
x
|
1.644
x
|
Free Cash Flow
1 |
10,391
|
13,428
|
15,745
|
13,450
|
10,395
|
9,197
|
11,300
|
12,279
|
ROE (net income / shareholders' equity)
|
15.1%
|
14.8%
|
15.5%
|
15.7%
|
15.2%
|
13.1%
|
12.9%
|
12.3%
|
ROA (Net income/ Total Assets)
|
4.41%
|
4.35%
|
4.82%
|
4.99%
|
4.72%
|
4.18%
|
4.41%
|
4.5%
|
Assets
1 |
1,50,315
|
1,64,974
|
1,64,261
|
83,216
|
1,76,918
|
2,12,402
|
2,21,647
|
2,36,251
|
Book Value Per Share
2 |
49.10
|
53.00
|
56.90
|
54.60
|
59.40
|
66.00
|
72.70
|
82.60
|
Cash Flow per Share
2 |
9.850
|
12.10
|
13.70
|
12.20
|
10.40
|
9.780
|
10.90
|
12.30
|
Capex
1 |
2,457
|
2,437
|
2,520
|
2,727
|
3,031
|
3,180
|
3,325
|
3,436
|
Capex / Sales
|
0.96%
|
0.91%
|
0.86%
|
0.85%
|
0.85%
|
0.86%
|
0.85%
|
0.82%
|
Announcement Date
|
12/02/20
|
16/02/21
|
09/02/22
|
08/02/23
|
07/02/24
|
-
|
-
|
-
|
Last Close Price
67.71
USD Average target price
87.96
USD Spread / Average Target +29.90% Consensus |
1st Jan change
|
Capi.
|
---|
| -14.25% | 85.35B | | +14.46% | 81.95B | | +9.37% | 28.99B | | -11.40% | 16.98B | | -0.36% | 16.85B | | +0.22% | 15.35B | | +4.32% | 12.42B | | -2.34% | 11.88B | | +32.69% | 12.19B | | -31.40% | 11.89B |
Other Healthcare Facilities & Services
|